Swiss National Bank’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.79M | Buy |
217,800
+16,800
| +8% | +$214K | ﹤0.01% | 1680 |
|
|
2025
Q4 | $1.81M | Buy |
201,000
+10,300
| +5% | +$142K | ﹤0.01% | 1916 |
|
|
2025
Q3 | $3.29M | Buy |
190,700
+3,300
| +2% | +$40.6K | ﹤0.01% | 1579 |
|
|
2025
Q2 | $1.76M | Hold |
187,400
| – | – | ﹤0.01% | 1871 |
|
|
2025
Q1 | $1.33M | Sell |
187,400
-2,300
| -1% | -$23.2K | ﹤0.01% | 1994 |
|
|
2024
Q4 | $2.21M | Buy |
189,700
+10,700
| +6% | +$167K | ﹤0.01% | 1790 |
|
|
2024
Q3 | $3.68M | Sell |
179,000
-1,300
| -0.7% | -$30K | ﹤0.01% | 1501 |
|
|
2024
Q2 | $4.04M | Buy |
180,300
+12,400
| +7% | +$295K | ﹤0.01% | 1400 |
|
|
2024
Q1 | $4.62M | Buy |
167,900
+2,200
| +1% | +$61.1K | ﹤0.01% | 1347 |
|
|
2023
Q4 | $5.05M | Sell |
165,700
-8,700
| -5% | -$250K | ﹤0.01% | 1292 |
|
|
2023
Q3 | $5.51M | Buy |
174,400
+1,900
| +1% | +$73.7K | ﹤0.01% | 1222 |
|
|
2023
Q2 | $7.03M | Buy |
172,500
+19,700
| +13% | +$799K | ﹤0.01% | 1104 |
|
|
2023
Q1 | $5.69M | Sell |
152,800
-12,400
| -8% | -$486K | ﹤0.01% | 1185 |
|
|
2022
Q4 | $5.76M | Buy |
165,200
+3,300
| +2% | +$157K | ﹤0.01% | 1229 |
|
|
2022
Q3 | $9.06M | Buy |
161,900
+4,100
| +3% | +$254K | 0.01% | 940 |
|
|
2022
Q2 | $8.17M | Sell |
157,800
-600
| -0.4% | -$30.5K | 0.01% | 1026 |
|
|
2022
Q1 | $11.5M | Buy |
158,400
+12,900
| +9% | +$1.09M | 0.01% | 938 |
|
|
2021
Q4 | $17.2M | Buy |
145,500
+9,900
| +7% | +$1.24M | 0.01% | 740 |
|
|
2021
Q3 | $18.2M | Buy |
135,600
+1,200
| +0.9% | +$182K | 0.01% | 710 |
|
|
2021
Q2 | $21.8M | Buy |
134,400
+26,400
| +24% | +$2.06M | 0.01% | 678 |
|
|
2021
Q1 | $8.67M | Buy |
108,000
+1,800
| +2% | +$121K | 0.01% | 1086 |
|
|
2020
Q4 | $5.78M | Buy |
106,200
+3,100
| +3% | +$113K | ﹤0.01% | 1275 |
|
|
2020
Q3 | $2.05M | Buy |
103,100
+1,500
| +1% | +$31.3K | ﹤0.01% | 1709 |
|
|
2020
Q2 | $2.14M | Buy |
101,600
+36,100
| +55% | +$613K | ﹤0.01% | 1677 |
|
|
2020
Q1 | $801K | Hold |
65,500
| – | – | ﹤0.01% | 1957 |
|
|
2019
Q4 | $961K | Buy |
65,500
+5,500
| +9% | +$76.5K | ﹤0.01% | 2163 |
|
|
2019
Q3 | $801K | Buy |
60,000
+1,100
| +2% | +$17.5K | ﹤0.01% | 2168 |
|
|
2019
Q2 | $964K | Buy |
58,900
+16,400
| +39% | +$258K | ﹤0.01% | 2131 |
|
|
2019
Q1 | $726K | Hold |
42,500
| – | – | ﹤0.01% | 2243 |
|
|
2018
Q4 | $580K | Hold |
42,500
| – | – | ﹤0.01% | 2294 |
|
|
2018
Q3 | $1.22M | Hold |
42,500
| – | – | ﹤0.01% | 2034 |
|
|
2018
Q2 | $1.16M | Buy |
42,500
+4,300
| +11% | +$104K | ﹤0.01% | 2072 |
|
|
2018
Q1 | $806K | Sell |
38,200
-1,500
| -4% | -$36.9K | ﹤0.01% | 2196 |
|
|
2017
Q4 | $763K | Buy |
39,700
+19,000
| +92% | +$439K | ﹤0.01% | 2236 |
|
|
2017
Q3 | $514K | Hold |
20,700
| – | – | ﹤0.01% | 2374 |
|
|
2017
Q2 | $331K | Hold |
20,700
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q1 | $292K | Hold |
20,700
| – | – | ﹤0.01% | 2489 |
|
|
2016
Q4 | $271K | Buy |
+20,700
| New | +$311K | ﹤0.01% | 2525 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
